Literature DB >> 9681125

Henoch-Schönlein purpura in Chinese children and adults.

S J Lin1, J L Huang.   

Abstract

From 1987 to 1996, we retrospectively analyzed 84 children and 38 adults admitted to Chang Gung Memorial Hospital with the diagnosis of Henoch-Schönlein purpura (HSP). All of the adult patients had skin biopsy finding showing leukocytoclastic vasculitis. Male predominance was noted in children, but not in adults. Preceding infection was noted in 40.5% of children and 31.6% of the adults (P = 0.46). 8.3% of children and 13.2% of adults had medication intake at disease onset (P = 0.62). Children had more frequent abdominal pain than the adults (70.2% vs 28.9%, P < 0.01). Renal involvement was more common and severe in adults, manifested as more frequent hypertension (P < 0.05) and heavy proteinuria (P < 0.01). During acute attack, leukocytosis, thrombocytosis, elevation of serum C-reactive protein levels were more frequently observed in children, while elevated serum IgA and cryoglobulin levels were more common in adults. The overall prognosis was good in both age groups, although two adults developed end stage renal disease. Our study demonstrated the different expression of HSP in Chinese children and adults.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681125

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  8 in total

1.  Nationwide epidemiological survey of childhood IgA vasculitis associated hospitalization in the USA.

Authors:  Yusuke Okubo; Kotaro Nochioka; Hiroshi Sakakibara; Hiroshi Hataya; Toshiro Terakawa; Marcia Testa; Robert P Sundel
Journal:  Clin Rheumatol       Date:  2016-09-05       Impact factor: 2.980

Review 2.  Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review.

Authors:  H Narchi
Journal:  Arch Dis Child       Date:  2005-05-04       Impact factor: 3.791

3.  The association between transforming growth factor-beta gene promoter C-509T polymorphism and Chinese children with Henoch-Schönlein purpura.

Authors:  Yao-Hsu Yang; Huey-Jen Lai; Cheng-Kai Kao; Yu-Tsan Lin; Bor-Luen Chiang
Journal:  Pediatr Nephrol       Date:  2004-07-15       Impact factor: 3.714

4.  Prediction of total body water in infants and children.

Authors:  J C K Wells; M S Fewtrell; P S W Davies; J E Williams; W A Coward; T J Cole
Journal:  Arch Dis Child       Date:  2005-09       Impact factor: 3.791

5.  Henoch schonlein purpura--a 5-year review and proposed pathway.

Authors:  Louise Watson; Amanda R W Richardson; Richard C L Holt; Caroline A Jones; Michael W Beresford
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

6.  Henoch-Schönlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center.

Authors:  Vanesa Calvo-Río; Javier Loricera; Cristina Mata; Luis Martín; Francisco Ortiz-Sanjuán; Lino Alvarez; M Carmen González-Vela; Domingo González-Lamuño; Javier Rueda-Gotor; Héctor Fernández-Llaca; Marcos A González-López; Susana Armesto; Enriqueta Peiró; Manuel Arias; Miguel A González-Gay; Ricardo Blanco
Journal:  Medicine (Baltimore)       Date:  2014-03       Impact factor: 1.889

7.  Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schönlein purpura.

Authors:  Yoon Kang; Jin-su Park; You-Jung Ha; Mi-il Kang; Hee-Jin Park; Sang-Won Lee; Soo-Kon Lee; Yong-Beom Park
Journal:  J Korean Med Sci       Date:  2014-01-28       Impact factor: 2.153

8.  Relapses in patients with Henoch-Schönlein purpura: Analysis of 417 patients from a single center.

Authors:  Vanesa Calvo-Río; José Luis Hernández; Francisco Ortiz-Sanjuán; Javier Loricera; Natalia Palmou-Fontana; Maria C González-Vela; Domingo González-Lamuño; Marcos A González-López; Susana Armesto; Ricardo Blanco; Miguel A González-Gay
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.